Navigator-Assisted Radiation Therapy for Breast and Prostate Cancer
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 420 (estimated)
- Sponsor
- University of Oklahoma · Other
This trial is looking for patients with breast or prostate cancer who are from underrepresented racial or ethnic groups. Participating involves receiving radiation therapy and may include support from patient navigators to help with treatment.
You may be able to join if
- I have been diagnosed with breast or prostate cancer.
- I am 18 years old or older.
- I am African American, Native American, or Hispanic.
- I am scheduled to have radiation therapy for cancer.
- I can understand and sign a consent document.
You may not be able to join if
- I am not African American, Native American, or Hispanic.
- I do not have confirmed breast or prostate cancer.
- I am under 18 years old.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
Loading trial locations…